Mechanisms of Neuromuscular Fatigue Post Stroke

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Stroke
Interventions
DRUG

duloxetine

Single dose, orally (pill), 30 mg, taken 6 hours prior to start of the testing session. Subjects will only take a single dose of duloxetine once.

DRUG

Cyproheptadine

Single dose, orally, 8 mg, 6 hours prior to the start of the respective testing session. Subjects will take a single dose of cyproheptadine once.

DRUG

Placebo

Single dose, orally, 6 hours prior to the start of the respective testing session. Subjects take a single dose once.

Trial Locations (1)

53201

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT01688570 - Mechanisms of Neuromuscular Fatigue Post Stroke | Biotech Hunter | Biotech Hunter